Clinical Trials
399 trialsA Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)
AstraZeneca
CLARA
Hospices Civils de Lyon
Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer
Radiation Therapy Oncology Group
Nivolumab Combined With Ipilimumab Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 214)
Bristol-Myers Squibb
ENDOLA
Hospices Civils de Lyon
Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma
M.D. Anderson Cancer Center
Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy
National Institutes of Health Clinical Center (CC)
SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors
Sarcoma Alliance for Research through Collaboration
Cabozantinib in Combination With 13-cis-Retinoic Acid in Children With Relapsed or Refractory Solid Tumors
University of California, San Diego
MINIVAB
Radboud University Medical Center
Bridge CRC
University of Illinois at Chicago
ADAPT NXT
argenx
SACHI
Hutchmed
FORTITUDE-101
Amgen
ASPIRES
Ann & Robert H Lurie Children's Hospital of Chicago
TRIFOUR
Cantargia AB
Care Plans for Cancer Predisposition
Children's Hospital of Philadelphia
Clinical Efficacy of QYHJ and Standard Chemotherapy in the Treatment of Advanced Pancreatic Cancer
Fudan University
Hyperpolarized Carbon-13 Alpha-ketoglutarate Imaging in IDH Mutant Glioma
University of California, San Francisco
HER Image
Amsterdam UMC, location VUmc
GC-CCP
RAND
A Trial of Y101D in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Advanced Pancreatic Cancer
Wuhan YZY Biopharma Co., Ltd.
CairnSurgical Breast Cancer Locator (BCL) Post-Market Study
CairnSurgical, Inc.
Effect of Silkworm Pupa Tablets in Gastrointestinal Malignancies at Nutritional Risk Following Radical Surgery
First Affiliated Hospital of Zhejiang University
A Clinical Study to Evaluate the Relative Bioavailability and Food Effect of HRS-8080 in Healthy Subjects
Shandong Suncadia Medicine Co., Ltd.
Quantitative Transmission Imaging Compared With MRI as Supplemental Screening for High Lifetime Risk of Breast Cancer
Mayo Clinic
Erector Spinae Plane Block in Laparoscopic Colorectal Cancer Surgery
Kayseri City Hospital
BuMelMCRN001
University Health Network, Toronto
NiloPost-STIM
University Hospital, Bordeaux
Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation
Memorial Sloan Kettering Cancer Center
Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy
Mayo Clinic
Rifaximin in Patients With Monoclonal Gammopathy
Emory University
CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone
Masonic Cancer Center, University of Minnesota
CD22-CAR T Cells in Children and Young Adults With B Cell Malignancies
Stanford University
ORCHID
Fudan University
Hair Loss Prevention Study for Pancreatic Cancer
HonorHealth Research Institute
MK-4280A-007
Merck Sharp & Dohme LLC
Spanish Meaning-Centered Psychotherapy for Cancer
University of Valencia
NEOS
Yonsei University
CHORDA-II-p
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
X-CLOSURE
Islamabad Medical and Dental College
Assessment of Safety, Quality, and Acceptance of a Bowel Preparation Using a Food Kit With Laxatives
Hunter Holmes Mcguire Veteran Affairs Medical Center
Effect of Myofeedback and Neuromuscular Electrical Stimulation on Hemiplegic Children After Brain Tumor Resection
Cairo University
Assessment of the Effect of Probiotic Supplementation on Proinflammatory Mechanisms Induced by Systemic Treatment in Women With Breast Cancer
Poznan University of Medical Sciences
Combination Chemotherapy, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Newly Diagnosed Large B-Cell Lymphoma
Centre Antoine Lacassagne
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma
Children's Oncology Group
Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma
Northwestern University
NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
POM MM 014
Celgene